상품명칭 |
프라바스타틴 1,1,3,3-테트라메틸 부틸아민 |
별명 |
[1S-[1a(S*,dS*),2a,6a,8(R*),8aa]]-1,2,6,7,8,8a-헥사하이드로-,d,6-트리하이드록시-2-메틸-8-(2-메틸-1-옥소부톡시)-1-나프탈렌헵타노에이트 2,4,4-트리메틸-2-펜탄아민 |
영문 이름 |
PRAVASTATIN 1,1,3,3-TETRAMETHYL BUTYLAMINE;[1S-[1a(S*,dS*),2a,6a,8(R*),8aa]]-1,2,6,7,8,8a-Hexahydro-,d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoate 2,4,4-Trimethyl-2-pentanamine |
분자식 |
C31H55NO7 |
분자량 |
553.7709 |
InChI |
InChI=1/C23H36O7.C8H19N/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28;1-7(2,3)6-8(4,5)9/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28);6,9H2,1-5H3/t13-,14-,16+,17+,18+,19-,20-,22-;/m0./s1 |
cas번호 |
151006-14-3 |
분자 구조 |
|
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|